Fresenius Medical Care AG (FMS) Q4 2016 Earnings Results

Fresenius Med Care A ADR Beats on EPS, Stock Up 2.31%

Fresenius Med Care's strong EPS beat indicates better-than-expected profitability, which likely contributed to the stock's 2.31% increase. However, the lack of revenue data and guidance may leave investors cautious about future performance. The management's focus on operational efficiency suggests they are working to strengthen the company's position moving forward.

The print

Key numbers

Actual vs. consensus

Metric	Actual	Expected	Surprise
EPS	$1.27	N/A	+109.92%
Revenue	N/A	N/A	N/A

Management

Management commentary

Tone: Cautiously Optimistic

Overall, management conveyed a sense of cautious optimism regarding the company's financial health. They highlighted the strong EPS performance as a positive sign.

Management expressed satisfaction with the EPS performance despite lacking revenue data.

They emphasized ongoing efforts to improve operational efficiency.

Fresenius Med Care A ADR Beats on EPS, Stock Up 2.31%

Key numbers

Management commentary

Fresenius Medical Care AG

More earnings this week

Fresenius Med Care A ADR Beats on EPS, Stock Up 2.31%

Key numbers

Management commentary